FDA clears MEDTOX' drugs-of-abuse test :
This article was originally published in Clinica
Executive Summary
MEDTOX Scientific, of St Paul, Minneapolis, has gained US FDA 510(k) clearance to market its rapid test for the qualitative detection of two drugs-of-abuse, ecstasy (methylenedioxymethamphetamine) and methamphetamine. The Verdict-II test is a one-step, immunochromatographic test that detects the drugs in urine.